Silvio Inderbitzin
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Silvio Inderbitzin currently works at Mavena International AG, as Chief Executive Officer, Hänseler Holding AG, as Chairman, Hthc High Tech Home Care AG, as Chairman from 2018, Vital Solutions Swiss AG, as Chairman from 2015, Ulrich Jüstrich Holding AG, as Director from 2015, Helvecura Cooperative Society, as Director, Hänseler AG, as Director from 2016, Krebsforschung Schweiz, as Director, Nexilis AG, as Director from 2015, Swiss Cancer Foundation, as Director, Aurealis Oy, as Director, Cellestia Biotech AG, as Director from 2022, Just Finance AG, as Director, Aurealis Therapeutics AG, as Director, Curatis Holding AG, as Non-Executive Director from 2022, Aurealis Pharma AG, as Director from 2016, Helvecura Genossenschaft, as Director, Artidis AG, as Director from 2016, and Kinarus AG, as Director.
Dr. Inderbitzin also formerly worked at Spexis Ltd., as Independent Director, Spirig Pharma AG, as Chief Executive Director & Director from 2012 to 2013, MEDUDEM AG, as Director, Kinarus Therapeutics Holding AG, as Director, Strekin AG, as Member-Supervisory Board, and Swiss Pharmaceutical Co. Ltd., as Head-Quality Assurance.
Dr. Inderbitzin received his Masters Business Admin degree in 2002 from the University of St. Gallen and doctorate degree in 1995 from the University of Zurich.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
1,39 % | 31/12/2025 | 71 778 ( 1,39 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Mavena International AG
Mavena International AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medical care products for the treatment of chronic skin conditions | Directeur Général | - |
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers | Directeur/Membre du Conseil | - |
Hänseler Holding AG | Président | - |
Helvecura Cooperative Society | Directeur/Membre du Conseil | - |
Hthc High Tech Home Care AG | Président | 01/01/2018 |
Ulrich Jüstrich Holding AG
Ulrich Jüstrich Holding AG Investment ManagersFinance Operates as an investment holding company | Directeur/Membre du Conseil | 01/01/2015 |
Just Finance AG | Directeur/Membre du Conseil | - |
Nexilis AG
Nexilis AG BiotechnologyHealth Technology Develops proprietary devices for fixation of implants in bones | Directeur/Membre du Conseil | 01/05/2015 |
Vital Solutions Swiss AG | Président | 01/01/2015 |
| ░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 26 |
|---|---|
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Ulrich Jüstrich Holding AG
Ulrich Jüstrich Holding AG Investment ManagersFinance Operates as an investment holding company | Finance |
Helvecura Cooperative Society | |
Hänseler AG
Hänseler AG Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
MEDUDEM AG
MEDUDEM AG Internet Software/ServicesTechnology Services Operates as an healthcare information services | Technology Services |
Krebsforschung Schweiz | |
Hänseler Holding AG | |
Nexilis AG
Nexilis AG BiotechnologyHealth Technology Develops proprietary devices for fixation of implants in bones | Health Technology |
Swiss Cancer Foundation | |
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers | Health Technology |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures anti-cancer drugs | Health Technology |
Mavena International AG
Mavena International AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medical care products for the treatment of chronic skin conditions | Health Technology |
Strekin AG
Strekin AG BiotechnologyHealth Technology Develops pharmaceuticals, therapeutics and vaccines | Health Technology |
Hthc High Tech Home Care AG | |
Just Finance AG | |
Vital Solutions Swiss AG | |
Swiss Pharmaceutical Co. Ltd.
Swiss Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Commercial Services |
Helvecura Genossenschaft | |
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Develops nano mechanical biomarker for rapid cancer diagnostics | Health Technology |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases | Health Technology |
Aurealis Therapeutics AG | |
Kinarus Therapeutics Holding AG
Kinarus Therapeutics Holding AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national